Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks

Lilly sold 36,931 shares of the Vancouver-based biopharmaceutical firm over the month of August.

Enjoy this blog? Please spread the word :)

%d bloggers like this: